Carcinogenic tobacco-specific nitrosamines induction of apurinic/apyrimidinic sites in DNA of human oral cells
致癌烟草特异性亚硝胺诱导人类口腔细胞 DNA 中的无嘌呤/无嘧啶位点
基本信息
- 批准号:10359388
- 负责人:
- 金额:$ 7.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-01-31 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
Cigarette smoking is the leading cause of lung and oral cancer in the United States. Smokeless tobacco causes
cancer of the mouth, esophagus and pancreas. The health effects of e-cigarettes are still under investigation but
may disturb oral cavity homeostasis and cause lung and cardiovascular diseases. The tobacco-specific
nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitrosonornicotine (NNN) are
classified as human carcinogens by the International Agency for Research on Cancer, and are recognized
causes of these diseases. Metabolic activation of NNK and NNN results in formation of reactive electrophiles
that modify DNA to produce a variety of products such as N7-[4-(3-pyridyl)-4-oxobut-1-yl]-deoxyguanosine
(N7POBdG) that can result in apurinic/apyrimidinic (AP) sites in DNA by facile hydrolysis of the base-
deoxyribonucleoside bond; other tobacco constituents may also induce AP sites. AP site accumulation may
initiate the carcinogenic process. Oral cells provide the direct link between tobacco use and oral cancer in
humans and elevated DNA damage has been found in oral cells of tobacco users. We propose to analyze AP
sites in oral cell DNA with two specific aims: to develop a highly sensitive mass spectrometric method to quantify
AP sites in human oral cell DNA, and to quantify AP sites in oral cell DNA induced by cigarette smoke, smokeless
tobacco and e-cigarettes. The goals are to establish oral cell DNA AP sites as biomarkers of tobacco induced
DNA damage in cigarette smokers, smokeless tobacco users, and e-cigarette users, and to ultimately identify
susceptible tobacco users and design effective strategies to prevent cancer. This study may also provide
preliminary data for a large epidemiologic study. We have strong preliminary data to support this proposal.
项目摘要
吸烟是美国肺癌和口腔癌的主要原因。无烟烟草原因
口腔,食道和胰腺癌。电子烟的健康影响仍在调查中,但
可能会干扰口腔稳态,并引起肺和心血管疾病。烟草特异性
硝基胺4-(甲基硝基氨基)-1-(3-吡啶基)-1-丁酮(NNK)和N'-硝酸盐(NNN)是
国际癌症研究机构归类为人类致癌物,并得到认可
这些疾病的原因。 NNK和NNN的代谢激活导致反应性电力的形成
这会改变DNA,以产生多种产品,例如N7- [4-(3-吡啶基)-4-氧化-1-基] -DeoxyGuanosine
(N7POBDG)可以通过便捷的基础水解来导致DNA中的apurinic/apyrimidinic(AP)位点
脱氧核苷键;其他烟草成分也可能引起AP位点。 AP站点的积累可能
启动致癌过程。口腔细胞提供烟草使用与口腔癌之间的直接联系
在烟草使用者的口腔细胞中发现了人类和DNA损伤升高。我们建议分析AP
口腔细胞DNA中具有两个特定目的的位点:开发高度敏感的质谱法以量化
人口腔细胞DNA中的AP位点,并量化由香烟烟雾诱导的口腔细胞DNA中的AP位点,无烟
烟草和电子烟。目标是建立口服细胞DNA AP位点作为烟草的生物标志物
吸烟者,无烟烟草使用者和电子烟使用者的DNA损害,并最终确定
易感烟草使用者和设计有效的策略来预防癌症。这项研究也可能提供
大型流行病学研究的初步数据。我们有强大的初步数据来支持该提案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Jiehong Guo的其他基金
Carcinogenic tobacco-specific nitrosamines induction of apurinic/apyrimidinic sites in DNA of human oral cells
致癌烟草特异性亚硝胺诱导人类口腔细胞 DNA 中的无嘌呤/无嘧啶位点
- 批准号:1085629910856299
- 财政年份:2023
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
Carcinogenic tobacco-specific nitrosamines induction of apurinic/apyrimidinic sites in DNA of human oral cells
致癌烟草特异性亚硝胺诱导人类口腔细胞 DNA 中的无嘌呤/无嘧啶位点
- 批准号:1055869810558698
- 财政年份:2022
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
相似海外基金
Carcinogenic tobacco-specific nitrosamines induction of apurinic/apyrimidinic sites in DNA of human oral cells
致癌烟草特异性亚硝胺诱导人类口腔细胞 DNA 中的无嘌呤/无嘧啶位点
- 批准号:1085629910856299
- 财政年份:2023
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
Project 2: Oxidative Stress and Harmful Constituent Levels Associated with Little Cigars
项目 2:与小雪茄相关的氧化应激和有害成分水平
- 批准号:1066589710665897
- 财政年份:2023
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
Carcinogenic tobacco-specific nitrosamines induction of apurinic/apyrimidinic sites in DNA of human oral cells
致癌烟草特异性亚硝胺诱导人类口腔细胞 DNA 中的无嘌呤/无嘧啶位点
- 批准号:1055869810558698
- 财政年份:2022
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens
西洋菜解毒环境毒物和致癌物的临床试验
- 批准号:1021455910214559
- 财政年份:2018
- 资助金额:$ 7.75万$ 7.75万
- 项目类别:
Clinical Trial of Watercress in Detoxification of Environmental Toxicants and Carcinogens
西洋菜解毒环境毒物和致癌物的临床试验
- 批准号:1045945410459454
- 财政年份:2018
- 资助金额:$ 7.75万$ 7.75万
- 项目类别: